Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D09QOR
|
||||
| Former ID |
DNCL002735
|
||||
| Drug Name |
Eniluracil
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Hyperlipidaemia [ICD9: 272.0-272.4; ICD10:E78] | Phase 2 | [525898] | ||
| Company |
Adherex Technologies
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C6H4N2O2
|
||||
| Canonical SMILES |
C#CC1=CNC(=O)NC1=O
|
||||
| InChI |
1S/C6H4N2O2/c1-2-4-3-7-6(10)8-5(4)9/h1,3H,(H2,7,8,9,10)
|
||||
| InChIKey |
JOZGNYDSEBIJDH-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID |
521438, 7468935, 7840073, 8178018, 12014705, 15170724, 34708593, 47205979, 50064965, 50878122, 57312787, 58107131, 91848806, 103426974, 104016559, 104341532, 126416503, 127319850, 127319851, 127319852, 127319853, 127319854, 127319855, 127319856, 127319857, 128306614, 132522685, 134224378, 135005757, 137030644, 137242733, 140105469, 152187794, 162262065, 163170165, 163410546, 163848391, 164840954, 172913632, 175426856, 179117033, 198972353, 223519221, 223741254, 226423521, 249548404, 250214752, 252075557, 252306248, 252423693
|
||||
| Target and Pathway | |||||
| Target(s) | Dihydropyrimidine dehydrogenase [NADP+] | Target Info | Modulator | [525898] | |
| PANTHER Pathway | Pyrimidine Metabolism | ||||
| PathWhiz Pathway | Beta-Alanine Metabolism | ||||
| Pyrimidine Metabolism | |||||
| WikiPathways | Metabolism of nucleotides | ||||
| Fluoropyrimidine Activity | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.